| VLTO |
Report |
Adj. EPS (Q2 2026) |
BEAT |
pred ~$1.04 vs. cons $1.01 |
MEDIUM |
| VLTO |
Report |
Core Sales Growth % (Q2 2026) |
BEAT |
pred ~3.8% vs. cons 3.5% |
MEDIUM |
| VLTO |
Report |
PQI Core Sales Growth % (Q2 2026) |
MISS |
pred ~1.5% vs. cons 2.5% |
MEDIUM |
| VLTO |
Guide |
Q3 2026 Adj. EPS (Q3 2026) |
LOWER |
guide ~$1.05 midpoint vs. cons $1.07 |
MEDIUM |
| VLTO |
Guide |
FY 2026 Adj. EPS (FY 2026) |
BETTER |
guide ~$4.32 midpoint vs. cons $4.25 |
MEDIUM |
| VLTO |
Guide |
FY 2026 Core Sales Growth (FY 2026) |
UNCHANGED |
guide maintained 3.0-4.5% vs. cons 3.9% |
HIGH |
| VLTO |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.5% |
— |
MEDIUM |
| VLTO |
Return |
5-day cumulative residual |
-0.5% (STABILIZE) |
STABILIZE — FY raise digested over 5 days, Q3 estimate cut creates ceiling; initial negative reaction fades but does not recover fully |
MEDIUM |